Use of Infliximab in the Treatment of Peripheral Ulcerative Keratitis in Crohn Disease
- 31 August 2011
- journal article
- case report
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 152 (2), 183-188.e2
- https://doi.org/10.1016/j.ajo.2011.01.059
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness
This publication has 28 references indexed in Scilit:
- Corneal Perforation Due to Severe Peripheral Ulcerative Keratitis in Crohn DiseaseCornea, 2006
- Inflammatory bowel disease and the eyeSurvey of Ophthalmology, 2003
- Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitorArthritis & Rheumatism, 2000
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)Gastroenterology, 1995
- Therapy of Nonnecrotizing Anterior Scleritis with Subconjunctival Corticosteroid InjectionOphthalmology, 1995
- Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.Gut, 1993
- Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.Gut, 1992
- Tumour necrosis factor alpha in stool as a marker of intestinal inflammationThe Lancet, 1992
- Ocular disorders in a series of 332 patients with Crohn's disease.British Journal of Ophthalmology, 1974